Alyeska Investment Group’s Adaptimmune Therapeutics ADAP Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-62,567	Closed	-$626K	–	448
2020 Q2	$626K	Buy	+62,567	New	+$626K	0.01%	407
2015 Q4	–	Sell	-118,419	Closed	-$1.42M	–	358
2015 Q3	$1.42M	Sell	118,419 -11,434	-9%	-$137K	0.02%	356
2015 Q2	$2.38M	Buy	+129,853	New	+$2.38M	0.03%	315